Literature DB >> 30187868

[Differences in expression profiles of circular RNA between luminal breast cancer cells and normal breast cells].

Bin Xiao1, Jiaxin Wen2, Chaoran Zhao2, Lidan Chen1, Zhaohui Sun1, Linhai Li1.   

Abstract

OBJECTIVE: To investigate the differences in the expression profiles of circular RNA (circRNA) between luminal breast cancer cells and normal breast cells.
METHODS: Total RNA extracted from luminal breast cancer cells MCF7 and normal breast cells MCF10A was digested with Rnase R to remove linear RNAs and enrich circRNAs. The enriched circRNAs were amplified and transcribed into fluorescent cRNAs using a random priming method, and were hybridized onto the circRNA hybridization array. The circRNA expression profiles of MCF7 and MCF10A cells were analyzed using Agilent Feature Extraction software. Quantile normalization and subsequent data processing were performed, and volcano plot filtering and hierarchical clustering were utilized to analyze the circRNA expression patterns. The expressions of 3 circRNAs with significant log fold changes were validated using qPCR.
RESULTS: The hybridization array data revealed significant differences in the circRNA expression profiles between MCF7 and MCF10A cells. Compared with those of MCF10A cells, the 12910 circRNAs expressed in MCF7 cells showed 5964 up-regulated, 81 consistently regulated, and 6865 down-regulated circRNAs; 343 circRNAs showed a log fold change by more than 2 folds, among which 213 circRNAs were up-regulated and 130 were down-regulated. Nine circRNAs showed differential expressions by more than 2 folds, including 8 up-regulated ones, namely hsa_circRNA_061260 (6.02 folds), hsa_circRNA_103933 (5.96 folds), hsa_circRNA_005239 (5.84 folds), hsa_circRNA_100689 (5.69 folds), hsa_circRNA_004087 (5.60 folds), hsa_circRNA_104420 (5.25 folds), hsa_circRNA_104421 (5.13 folds) and hsa_circRNA_101222 (5.03 folds); only one circRNA was down-regulated, namely hsa_circRNA_104864 (5.09 folds). The expressions of hsa_circRNA_100689, hsa_circRNA_005239 and hsa_circRNA_104864 were further validated by qPCR, which yielded consistent results with the microarray data.
CONCLUSIONS: The circRNA expression profiles differ significantly between luminal breast cancer cells and normal breast cells. These differentially expressed circRNAs may serve as potential novel targets for the diagnosis of luminal breast cancer.

Entities:  

Keywords:  breast cancer; circRNA; expression profiles; luminal type

Mesh:

Substances:

Year:  2018        PMID: 30187868      PMCID: PMC6744033          DOI: 10.3969/j.issn.1673-4254.2018.08.19

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

Review 1.  Breast cancer classification: linking molecular mechanisms to disease prognosis.

Authors:  Atefeh Taherian-Fard; Sriganesh Srihari; Mark A Ragan
Journal:  Brief Bioinform       Date:  2014-06-20       Impact factor: 11.622

2.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer.

Authors:  Peifei Li; Shengcan Chen; Huilin Chen; Xiaoyan Mo; Tianwen Li; Yongfu Shao; Bingxiu Xiao; Junming Guo
Journal:  Clin Chim Acta       Date:  2015-02-14       Impact factor: 3.786

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.

Authors:  S J Santner; P J Dawson; L Tait; H D Soule; J Eliason; A N Mohamed; S R Wolman; G H Heppner; F R Miller
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

5.  Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.

Authors:  Shannon T Bailey; Thomas Westerling; Myles Brown
Journal:  Cancer Res       Date:  2014-11-11       Impact factor: 12.701

Review 6.  The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research.

Authors:  Şerban Comşa; Anca Maria Cîmpean; Marius Raica
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

7.  Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.

Authors:  Meilin Qin; Gang Liu; Xisong Huo; Xuemei Tao; Xiaomeng Sun; Zhouhong Ge; Juan Yang; Jia Fan; Lei Liu; Wenxin Qin
Journal:  Cancer Biomark       Date:  2016       Impact factor: 4.388

8.  The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.

Authors:  Xiangsheng Xiao; Xiaojia Huang; Feng Ye; Bo Chen; Cailu Song; Jiahuai Wen; Zhijie Zhang; Guopei Zheng; Hailin Tang; Xiaoming Xie
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

9.  Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.

Authors:  Lingshuang Lü; Jian Sun; Peiyi Shi; Weimin Kong; Kun Xu; Biyu He; Simin Zhang; Jianming Wang
Journal:  Oncotarget       Date:  2017-07-04

10.  Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.

Authors:  Juan Chen; Juan Xu; Yongsheng Li; Jinwen Zhang; Hong Chen; Jianping Lu; Zishan Wang; Xueying Zhao; Kang Xu; Yixue Li; Xia Li; Yan Zhang
Journal:  Oncotarget       Date:  2017-02-07
View more
  1 in total

1.  Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p.

Authors:  Fada Xia; Yong Chen; Bo Jiang; Ning Bai; Xinying Li
Journal:  Cancer Cell Int       Date:  2020-02-13       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.